Figures
Abstract
Introduction
Ventilatory efficiency (VE/VCO2 slope) has been shown superior to peak oxygen consumption (VO2) for prediction of post-operative pulmonary complications in patients undergoing thoracotomy. VE/VCO2 slope is determined by ventilatory drive and ventilation/perfusion mismatch whereas VO2 is related to cardiac output and arteriovenous oxygen difference. We hypothesized pre-operative VO2 predicts post-operative cardiovascular complications in patients undergoing lung resection.
Methods
Lung resection candidates from a published study were evaluated by post-hoc analysis. All of the patients underwent preoperative cardiopulmonary exercise testing. Post-operative cardiovascular complications were assessed during the first 30 post-operative days or hospital stay. One-way analysis of variance or the Kruskal–Wallis test, and multivariate logistic regression were used for statistical analysis and data summarized as median (IQR).
Results
Of 353 subjects, 30 (9%) developed pulmonary complications only (excluded from further analysis), while 78 subjects (22%) developed cardiovascular complications and were divided into two groups for analysis: cardiovascular only (n = 49) and cardiovascular with pulmonary complications (n = 29). Compared to patients without complications (n = 245), peak VO2 was significantly lower in the cardiovascular with pulmonary complications group [19.9 ml/kg/min (16.5–25) vs. 16.3 ml/kg/min (15–20.3); P<0.01] but not in the cardiovascular only complications group [19.9 ml/kg/min (16.5–25) vs 19.0 ml/kg/min (16–23.1); P = 0.18]. In contrast, VE/VCO2 slope was significantly higher in both cardiovascular only [29 (25–33) vs. 31 (27–37); P = 0.05] and cardiovascular with pulmonary complication groups [29 (25–33) vs. 37 (34–42); P<0.01)]. Logistic regression analysis showed VE/VCO2 slope [OR = 1.06; 95%CI (1.01–1.11); P = 0.01; AUC = 0.74], but not peak VO2 to be independently associated with post-operative cardiovascular complications.
Citation: Mazur A, Brat K, Homolka P, Merta Z, Svoboda M, Bratova M, et al. (2022) Ventilatory efficiency is superior to peak oxygen uptake for prediction of lung resection cardiovascular complications. PLoS ONE 17(8): e0272984. https://doi.org/10.1371/journal.pone.0272984
Editor: Juliana Goulart Prata Oliveira Milani, University of Brasilia: Universidade de Brasilia, BRAZIL
Received: February 23, 2022; Accepted: July 29, 2022; Published: August 12, 2022
Copyright: © 2022 Mazur et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: - IC and KB received the award - Supported by Ministry of Health of the Czech Republic research grant [NU21-06-00086] - Ministry of Health of the Czech Republic - https://www.isvavai.cz/cep?s=jednoduche-vyhledavani&ss=detail&h=NU21-06-00086 - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Peak oxygen consumption (VO2) is recommended by both American and European guidelines for pre-operative risk stratification of lung resection candidates [1,2]. However, over the last decade, several studies have shown peak VO2 to be a poor predictor of post-operative pulmonary complications [3] and inferior to ventilatory efficiency (VE/VCO2 slope) [4,5].
By the alveolar gas equation ventilatory efficiency is defined as VE/VCO2 = 863 / (PaCO2 x (1—VD /VT)) [6]. Therefore, VE/VCO2 is increased by lower PaCO2 (hyperventilation) or increase of the VD /VT ratio (ventilation/perfusion mismatch or ineffective breathing pattern with rapid and shallow breathing) which may explain its superior prediction of post-operative pulmonary complications [6].
In contrast, determinants of VO2 include cardiac output [7] and arteriovenous oxygen difference. Peak VO2 is considered a cardiovascular fitness parameter [8] and was shown to be a major risk factor for post-operative cardiovascular complications [9]. Hence, an association with cardiovascular complications might be expected.
We hypothesized peak exercise VO2 predicts post-operative cardiovascular complications in patients undergoing thoracic surgery. Accordingly, the aim of this study was to compare pre-operative peak exercise VO2 and VE/VCO2 slope in the prediction of post-operative cardiovascular complications in patients after lung resection surgery.
Methods
Subject selection
Subjects included were consecutive patients who underwent lung resection surgery. Inclusion criteria were age ≥18 years and ability to undergo cardiopulmonary exercise testing (CPET). Exclusion criteria were contraindication for lung resection because of inoperability or low peak predicted post-operative VO2 [VO2<10ml/kg/min or <35% predicted together with predicted post-operative forced expiratory volume at one second (FEV1) <30% and diffusing capacity for carbon monoxide (DLCO) <30% 2)] and development of pulmonary complications only.
Study design
This is a post-hoc analysis of a previously published prospective multicenter study which evaluated pre-operative rest ventilatory parameters as predictors of post-operative pulmonary complications in lung resection candidates [10]. All of the included patients underwent preoperative CPET and pulmonary function tests. Post-operative cardiovascular complications were prospectively accessed from the first 30 post-operative days or from the hospital stay. The study was conducted in accordance with the declaration of Helsinki. All participants provided written informed consent and the study was approved by the local Ethics Committee of St. Anne’s University Hospital in Brno (reference No. 19JS/2017, date of approval April 12, 2017; reference No. 2G/2018, date of approval March 21st, 2018) and by the local Ethics Committee of the University Hospital Brno (reference No. 150617/EK, date of approval June 19th, 2017). The study was registered at ClinicalTrials.gov (NCT03498352) and the manuscript adheres to the applicable STROBE guidelines.
Cardiopulmonary exercise testing
Exercise capacity was assessed by CPET as described previously [10]. Subjects underwent preoperative CPET (symptom-limited) using a bicycle ergometer (Ergoline, Ergometrics 800®, Bitz, Germany). Expired gas analysis was done with the use of a PowerCube-Ergo® cardiopulmonary exercise system (Ganshorn Medizin Electronic GmbH, Niederlauer, Germany). Arterial blood gas analysis was done twice (at rest and peak exercise) using the ABL90 Flex Plus® (Radiometer Medical ApS, Denmark) device. The CPET protocol included a warm-up phase without resistance (60 seconds) followed by a linearly increasing (15 W/min) ramp protocol. Measured parameters included VO2, carbon dioxide output (VCO2), breathing frequency (fb), tidal volume (VT), minute ventilation (VE) and PETCO2. The derived CPET parameters included dead space to tidal volume ratio (VD/VT), respiratory exchange ratio (RER) and VE/VCO2 slope.
Pulmonary function tests
Spirometry was performed using the ZAN100 device (nSpire Health, Inc., USA) and DLCO using the PowerCube Diffusion+ device (Ganshorn Medizin Electronic GmbH, Germany). Analyzed parameters include forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and FEV1/FVC ratio and were reported as percent (%) of predicted value.
Cardiovascular complications
Cardiovascular complications were defined as previously recommended [11] and prospectively assessed from the first 30 post-operative days or from the hospital stay including arrhythmias (atrial fibrillation, supraventricular tachycardia–duration ≥ 10 seconds [12]); hypotension (catecholamine administration or parenteral fluids >200ml/h); heart failure (recently elevated serum brain natriuretic peptide and/or administration of inotropes); pulmonary edema (chest X-ray + clinical signs); pulmonary embolism (CT-angiography or highly suspicious right heart echocardiography signs); myocardial infarction/minimal myocardial lesion (coronary angiography or new ECG signs with serum positive troponin), stroke (newly developed neurological deficit with CT signs of brain infarction of ischemic or hemorrhagic etiology [13]) and cardiopulmonary resuscitation.
Pulmonary complications
Pulmonary complications were assessed as previously described by our group [10] and others [4,14] and included pneumonia; atelectasis; respiratory failure requiring mechanical ventilation; adult respiratory distress syndrome and tracheostomy. ICU length of stay (LOS), hospital LOS and 30-day mortality were also monitored. Surgical Mortality Probability Model (S-MPM), an ASA (American Society of Anesthesiologists) physical status adjusted for surgery risk class and emergency status [15], was used to allow patient’s co-morbidities comparison.
Statistics
The Shapiro-Wilk test was used to evaluate normality. One-way analysis of variance or the Kruskal–Wallis test by ranks followed by either post-hoc Tukey HSD test or Mann–Whitney U test (as appropriate) were used to test for differences among the groups. Chi-square test was used to compare categorical variables. Univariate logistic regression was done for parameters significantly different between groups. The Spearman rank test was performed to evaluate parameters with significant correlation. Parameters with correlation coefficients <±0.5 were used for multivariate stepwise logistic and linear regression. A multivariate stepwise logistic regression model was constructed to analyze which parameters were independently associated with the development of cardiovascular complications, ICU readmission and 30-day mortality. To evaluate model performance receiver operating characteristic (ROC) analyses were performed. Multivariate stepwise linear regression analyses (using same parameters as for multivariate logistic regression) were performed to evaluate the association of peak VO2 and VE/VCO2 slope with hospital and ICU LOS. Data are summarized as mean ± SD or median (IQR) as appropriate; P values <0.05 were considered statistically significant. Statistica software 12.0 (StatSoft Inc., Prague, Czech Republic) and IBM SPSS Statistics 25.0 (IBM Corp, USA) were used for analysis.
Results
Data from 353 lung resection surgery candidates from our previous study [10] were analyzed. Thirty patients (9%) developed pulmonary complications only and were excluded; 78 patients (22%) developed cardiovascular complications and 245 patients (69%) had no complications. Comparison of patients with and without cardiovascular complications is shown in S1 Table. Out of the 78 patients with cardiovascular complications, 49 patients developed cardiovascular complications only and 29 patients developed cardiovascular with pulmonary complications. Cardiovascular and pulmonary complications often coexist [16], and despite prospective assessment of complications, we were not able to fully distinguish which complications were primary and which were secondary. To mitigate this, we divided our cardiovascular complications subjects into 2 groups–cardiovascular only and cardiovascular with pulmonary complications (frequency of cardiovascular complications was nearly the same in both groups Table 1) and analyzed them separately.
Subject and surgery characteristics are shown in Table 2. Subjects in both the post-operative cardiovascular complications groups were significantly older and had higher S-MPM and comorbidities. Hospital and ICU LOS was significantly longer and frequency of ICU readmissions higher in both cardiovascular complication groups. The 30-day mortality was significantly higher in the cardiovascular with pulmonary complications group.
Results of pulmonary function tests and arterial blood gases are summarized in Table 3. FEV1%, FVC%, FEV1/FVC% and DLCO% and rest PaO2 were significantly lower in the cardiovascular with pulmonary complications group. FEV1/FVC% was also lower in the cardiovascular complications only group.
Rest and exercise ventilatory parameters for all groups are summarized in Table 4. At rest, PETCO2 was significantly lower in both cardiovascular complication groups. At peak exercise, VO2, VCO2, RER and VT were significantly lower and fb significantly higher in the cardiovascular with pulmonary complications group. Peak exercise PETCO2 was lower and VE/VCO2 slope higher in both cardiovascular complication groups.
Univariate logistic regression demonstrated VE/VCO2 slope to be significantly associated with cardiovascular complications (OR = 1.10; 95%CI 1.06–1.15; P<0.01; AUC = 0.67) and ICU readmissions (OR = 0.92; 95% CI 0.85–0.99; P = 0.02; AUC = 0.71). Patients with VE/VCO2 slope ≥34.8 had significantly higher probability (17.4% vs. 46.1%) for post-operative cardiovascular complications with OR 4.1 (95% CI 2.3–7.1; P<0.01). However, VE/VCO2 slope association with 30-day mortality was not significant (OR = 0.93; 95%CI 0.85–1.01; P = 0.08; AUC = 0.68). While peak VO2 was significantly associated with cardiovascular complications (OR = 0.93; 95% CI 0.89–0.98; P<0.01; AUC = 0.60), it was not associated with ICU readmissions (OR = 1.05; 95% CI 0.95–1.16; P = 0.36; AUC = 0.56) or 30-day mortality (OR = 1.11; 0.97–1.28; P = 0.14; AUC = 0.61).
Multivariate logistic regression showed VE/VCO2 slope, age, and wedge resection, but not peak VO2 to be independently associated with post-operative cardiovascular complications (Table 5) with AUC 0.75 (Fig 1). VE/VCO2 slope also remained significantly associated with ICU readmissions (OR = 0.92; 95% CI 0.86–0.99; P = 0.03; AUC = 0.70).
Multivariate logistic regression model [AUC = 0.747 (0.687; 0.807)].
Both peak VO2 and VE/VCO2 significantly correlated with ICU LOS (rho = -0.13, P = 0.02; rho = 0.38, P<0.01, respectively) and hospital LOS (rho = -0.13, P = 0.02; rho = 0.34, P<0.01, respectively). Multiple stepwise regression analysis showed VE/VCO2 slope, but not peak VO2 to be significantly associated with ICU LOS (b = 0.13, F = 9, P<0.01) and hospital LOS (b = 0.19, F9.7, P<0.01).
Discussion
A major finding of this post-hoc analysis of a previously reported surgical cohort was that peak exercise VO2 did not predict post-operative cardiovascular complications, ICU readmissions, mortality, and hospital and ICU LOS in lung resection candidates. However, in contrast VE/VCO2 slope predicted post-operative cardiovascular complications, ICU readmissions, and hospital and ICU LOS.
The incidence of post-operative cardiovascular complications was 22%, similar to previous reports [17,18]. The most frequent cardiovascular complication was supraventricular arrhythmia (60%) in agreement with previous studies of post-lung resection surgery [18,19]. The second most common complication was post-operative hypotension (58%), which is also frequent [20]. Although these complications may be considered mild, post-operative arrhythmias are associated with longer hospital LOS, intensive care unit admissions, resource utilization and costs of care [17,21] and post-operative hypotension may be associated with myocardial injury [20]. Indeed, in our cohort, ICU readmissions were greater and hospital and ICU LOS were significantly longer in both cardiovascular complication groups. Severe complications (except of hypotension and arrhythmia) were relatively rare (16%) and developed in only 10 patients.
Compared to patients without post-operative complications, patients who developed cardiovascular complications (with or without pulmonary complications) were significantly older, had more comorbidities and lower pre-operative FEV1/FVC%. Lobectomy was more frequent and wedge resection less frequent in these patients, in concordance with previous studies [17,18]. In our study, patients with a combination of cardiovascular and pulmonary complications had previously established risk factors for post-operative pulmonary complications including thoracotomy, lower FEV1%, FVC%, DLCO% and PaO2 [22,23]. The 30-day mortality was also higher in this group of patients.
During pre-operative exercise, patients with post-operative cardiovascular complications (with or without pulmonary complications) exhibited significantly higher VE/VCO2 slope. In contrast, peak VO2 was significantly lower only in the cardiovascular with pulmonary complications group. VE/VCO2 slope is determined by ventilatory control impairment [6] suggesting it may be a parameter which is predictive of post-operative pulmonary complications. Indeed, several studies have previously shown its superiority to peak VO2 [4,5,10,14,24,25]. However, the main determinant of peak VO2 is cardiac output [7], which has been shown to be a major risk factor for post-operative cardiovascular complications [9].
Peak VO2 is considered a parameter for assessment of cardiovascular fitness [8]. Hence, an association with cardiovascular complications might be expected. However, in this study, although the peak VO2 was significantly associated with cardiovascular complications by univariate analysis, multivariate logistic regression showed that only VE/VCO2 slope, type of surgical procedure and age were independently associated with cardiovascular complications. This is in agreement with prior studies in chronic heart failure patients where VE/VCO2 slope has also been found superior to peak VO2 in the prediction of cardiovascular events [26–28]. The observed association of VE/VCO2 slope and cardiovascular complications might be explained by an inverse association of VE/VCO2 slope with cardiac output and positive association with capillary wedge pressure [29]. Moreover, unlike peak VO2, VE/VCO2 slope is independent of patient effort and peripheral skeletal muscle function enabling acquisition during submaximal exercise (VE/VCO2 has been validated across different RER [30]) which may be beneficial for assessment of functionally limited lung surgery candidates.
Our findings may have clinical implications. First, peak VO2 is part of risk stratification algorithms in both American and European guidelines [1,2]. However, multiple studies have previously shown its poor prognostic utility [3–5,10]. In contrast, VE/VCO2 slope has been shown to be significantly better in the prediction of pulmonary [4,5,10,14,24,25] and now also cardiovascular complications. Accordingly, we suggest that lung resection candidate risk stratification algorithms consider routine inclusion of VE/VCO2 slope. Second, pre-operative risk stratification may allow pre-operative patient optimization as VE/VCO2 slope may be a therapeutic target [31] and promote better perioperative planning [17].
This study has several limitations. First, according to published ERS/ESTS guidelines [2], subjects with peak predicted post-operative VO2<10ml/kg/min were excluded, which may diminish the predictive value of peak VO2. However, only 6 subjects from our study cohort were excluded for this reason. Second, chronic medication data were unavailable. However, chronic medication is usually associated with the underlying diseases and our logistic regression analysis was adjusted for those. Third, PaO2 was significantly lower in patients with cardiovascular and pulmonary complications at rest. As VO2 is determined not only by cardiac output but also arteriovenous oxygen difference, this may have contributed to the observed VO2 differences (although these were observed only at peak exercise). Therefore, we cannot exclude, that peak VO2 may be a relevant prognostic factor in this subgroup of severely ill patients.
Conclusion
Peak VO2 is a poor predictor of post-operative cardiovascular complications. In contrast, the VE/VCO2 slope predicted post-operative cardiovascular complications, ICU readmissions and both hospital and ICU LOS. Our observations suggest consideration of routine inclusion of VE/VCO2 slope for pre-operative risk stratification in lung resection candidates.
Supporting information
S1 Table. Comparison of patients with and without cardiovascular complications.
Comparison of patients with and without cardiovascular complications.
https://doi.org/10.1371/journal.pone.0272984.s001
(DOCX)
References
- 1. Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ. Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST. 2013 May 1;143(5):e166S–e190S. pmid:23649437
- 2. Brunelli A, Charloux A, Bolliger CT, Rocco G, Sculier JP, Varela G, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). European Respiratory Journal. 2009 Jul 1;34(1):17–41. pmid:19567600
- 3. Begum SSS, Papagiannopoulos K, Falcoz PE, Decaluwe H, Salati M, Brunelli A. Outcome after video-assisted thoracoscopic surgery and open pulmonary lobectomy in patients with low VO 2 max: a case-matched analysis from the ESTS database †. European Journal of Cardio-Thoracic Surgery. 2016 Apr 1;49(4):1054–8. pmid:26604295
- 4. Brunelli A, Belardinelli R, Pompili C, Xiumé F, Refai M, Salati M, et al. Minute ventilation-to-carbon dioxide output (VE/VCO2) slope is the strongest predictor of respiratory complications and death after pulmonary resection. Ann Thorac Surg. 2012 Jun;93(6):1802–6. pmid:22560968
- 5. Shafiek H, Valera JL, Togores B, Torrecilla JA, Sauleda J, Cosío BG. Risk of postoperative complications in chronic obstructive lung diseases patients considered fit for lung cancer surgery: beyond oxygen consumption. Eur J Cardiothorac Surg. 2016 Oct;50(4):772–9. pmid:27059429
- 6. Woods PR, Olson TP, Frantz RP, Johnson BD. Causes of breathing inefficiency during exercise in heart failure. J Card Fail. 2010 Oct;16(10):835–42. pmid:20932466
- 7. Beck KC, Randolph LN, Bailey KR, Wood CM, Snyder EM, Johnson BD. Relationship between cardiac output and oxygen consumption during upright cycle exercise in healthy humans. Journal of Applied Physiology. 2006 Nov 1;101(5):1474–80. pmid:16873603
- 8. Swank AM, Horton J, Fleg JL, Fonarow GC, Keteyian S, Goldberg L, et al. Modest Increase in Peak VO2 Is Related to Better Clinical Outcomes in Chronic Heart Failure Patients. Circulation: Heart Failure. 2012 Sep 1;5(5):579–85. pmid:22773109
- 9. Sellers D, Srinivas C, Djaiani G. Cardiovascular complications after non-cardiac surgery. Anaesthesia. 2018;73(S1):34–42. pmid:29313903
- 10. Brat K, Homolka P, Merta Z, Chobola M, Heroutova M, Bratova M, et al. Prediction of Postoperative Complications: Ventilatory Efficiency and Rest End-tidal Carbon Dioxide. The Annals of Thoracic Surgery [Internet]. 2022 Jan 21 [cited 2022 Jan 25]; Available from: https://www.sciencedirect.com/science/article/pii/S0003497522000601. pmid:35074321
- 11. Bennett-Guerrero E, Welsby I, Dunn TJ, Young LR, Wahl TA, Diers TL, et al. The Use of a Postoperative Morbidity Survey to Evaluate Patients with Prolonged Hospitalization After Routine, Moderate-Risk, Elective Surgery. Anesthesia & Analgesia. 1999 Aug;89(2):514–9. pmid:10439777
- 12. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010 Oct;12(10):1360–420. pmid:20876603
- 13. Mashour GA, Moore LE, Lele AV, Robicsek SA, Gelb AW. Perioperative care of patients at high risk for stroke during or after non-cardiac, non-neurologic surgery: consensus statement from the Society for Neuroscience in Anesthesiology and Critical Care*. J Neurosurg Anesthesiol. 2014 Oct;26(4):273–85. pmid:24978064
- 14. Torchio R, Guglielmo M, Giardino R, Ardissone F, Ciacco C, Gulotta C, et al. Exercise ventilatory inefficiency and mortality in patients with chronic obstructive pulmonary disease undergoing surgery for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2010 Jul;38(1):14–9. pmid:20356758
- 15. Kazimierczak S, Rybicka A, Strauss J, Schram M, Kazimierczak A, Grochans E. External Validation Of The Surgical Mortality Probability Model (S-MPM) In Patients Undergoing Non-Cardiac Surgery. Ther Clin Risk Manag. 2019 Oct 4;15:1173–82. pmid:31632044
- 16. Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac Complications in Patients With Community-Acquired Pneumonia. Circulation. 2012 nor;125(6):773–81. pmid:22219349
- 17. Ferguson MK, Saha-Chaudhuri P, Mitchell JD, Varela G, Brunelli A. Prediction of major cardiovascular events after lung resection using a modified scoring system. Ann Thorac Surg. 2014 Apr;97(4):1135–40. pmid:24565405
- 18. Decker KD, Jorens PG, Schil PV. Cardiac complications after noncardiac thoracic surgery: an evidence-based current review. The Annals of Thoracic Surgery. 2003 Apr 1;75(4):1340–8. pmid:12683600
- 19. Asamura H. Early complications. Cardiac complications. Chest Surg Clin N Am. 1999 Aug;9(3):527–41, vii–viii. pmid:10459428
- 20. Liem VGB, Hoeks SE, Mol KHJM, Potters JW, Grüne F, Stolker RJ, et al. Postoperative Hypotension after Noncardiac Surgery and the Association with Myocardial Injury. Anesthesiology. 2020 Sep 1;133(3):510–22. pmid:32487822
- 21. Smith H, Li H, Brandts-Longtin O, Yeung C, Maziak D, Gilbert S, et al. External validity of a model to predict postoperative atrial fibrillation after thoracic surgery. European Journal of Cardio-Thoracic Surgery. 2020 May 1;57(5):874–80. pmid:31845993
- 22. Jean RA, DeLuzio MR, Kraev AI, Wang G, Boffa DJ, Detterbeck FC, et al. Analyzing Risk Factors for Morbidity and Mortality after Lung Resection for Lung Cancer Using the NSQIP Database. J Am Coll Surg. 2016 Jun;222(6):992–1000.e1. pmid:27118714
- 23. Salati M, Refai M, Pompili C, Xiumè F, Sabbatini A, Brunelli A. Major morbidity after lung resection: a comparison between the European Society of Thoracic Surgeons Database system and the Thoracic Morbidity and Mortality system. J Thorac Dis. 2013 Jun;5(3):217–22. pmid:23825750
- 24. Miyazaki T, Callister MEJ, Franks K, Dinesh P, Nagayasu T, Brunelli A. Minute ventilation-to-carbon dioxide slope is associated with postoperative survival after anatomical lung resection. Lung Cancer. 2018 Nov 1;125:218–22. pmid:30429023
- 25. Brat K, Tothova Z, Merta Z, Taskova A, Homolka P, Vasakova M, et al. Resting End-Tidal Carbon Dioxide Predicts Respiratory Complications in Patients Undergoing Thoracic Surgical Procedures. The Annals of Thoracic Surgery. 2016 Nov;102(5):1725–30. pmid:27496629
- 26. Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J. 2004 Feb;147(2):354–60. pmid:14760336
- 27. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol. 1997 Jun;29(7):1585–90. pmid:9180123
- 28. Kleber FX, Vietzke G, Wernecke KD, Bauer U, Opitz C, Wensel R, et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation. 2000 Jun 20;101(24):2803–9. pmid:10859285
- 29. Nayor M, Xanthakis V, Tanguay M, Blodgett JB, Shah RV, Schoenike M, et al. Clinical and Hemodynamic Associations and Prognostic Implications of Ventilatory Efficiency in Patients With Preserved Left Ventricular Systolic Function. Circulation: Heart Failure. 2020 May 1;13(5):e006729. pmid:32362167
- 30. Chase PJ, Kenjale A, Cahalin LP, Arena R, Davis PG, Myers J, et al. Effects of respiratory exchange ratio on the prognostic value of peak oxygen consumption and ventilatory efficiency in patients with systolic heart failure. JACC Heart Fail. 2013 Oct;1(5):427–32. pmid:24621975
- 31. Gademan MGJ, Swenne CA, Verwey HF, van de Vooren H, Haest JCW, van Exel HJ, et al. Exercise training increases oxygen uptake efficiency slope in chronic heart failure. European Journal of Cardiovascular Prevention & Rehabilitation. 2008 Apr 1;15(2):140–4. pmid:18391638